Changes in plasma high density lipoproteins (HDL) levels after salbutamol.
Administration of salbutamol--in a single dose of 0.5 mg i.v. and in a dose of 8 mg twice daily during two weeks--was associated with an increase of HDL-cholesterol concentration in the serum of patients with chronic bronchitis and severe airway obstruction. At the end of the second week of oral treatment with salbutamol, the HDL-cholesterol concentration in serum increased by 6.9% (p less than 0.01).
D000420:Albuterol / Q000494:pharmacology / Q000627:therapeutic use*; D001991:Bronchitis / Q000097:blood / Q000188:drug therapy*; D008076:Cholesterol, HDL / Q000097:blood*; D006801:Humans; D013268:Stimulation, Chemical; D013997:Time Factors
D008076:Cholesterol, HDL; D000420:Albuterol